We analyzed data from 129 patients enrolled on 19 lung cancer trials with mandatory or optional tumor tissue submission to determine impact of these requirements on treatment timelines and staff effort. On average, tissue requirements delayed treatment initiation 21 days and required 3 staff communications. Improved systems to expedite these processes and use of non-tissue-based biomarkers may address these issues.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2q0bCWz
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Background Hyperthyroidism is associated with increased thrombotic risk. As contact system activation through formation of neutrophil extrac...
-
Abstract Helmet manufacturers recommend replacing a bicycle helmet after an impact or after anywhere from 2 to 10 years of use. The goal o...
-
Caring for Patients with Physical Disabilities: Assessment of an Innovative Spinal Cord Injury Session that Addresses an Educational Gap Des...
-
Abstract Objective To evaluate Chinese medicine (CM) formula Bazheng Powder (八正散) as an alternative therapeutic option for female patients...
-
Abstract Electro-Fenton (EF), an advanced oxidation process, can be combined with a biological process for efficient treatment of wastewate...
-
ACS Nano DOI: 10.1021/acsnano.6b07082 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2j1vZRU via...
-
ABSTRACT Polygenic scores (PGS) summarize the genetic contribution of a person's genotype to a disease or phenotype. They can be used ...
-
bmj;356/mar29_1/j1571/FAF1faKunal Patel/Hindustani Times/Getty ImagesNearly 40 000 doctors in Delhi and Mumbai have gone on strike to demand...
-
Abstract Background Volasertib, a potent and selective polo-like kinase inhibitor, has shown to increase response rates and improve surv...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου